



LCAT Antibody (D-3) is a mouse monoclonal IgG2a antibody that detects lecithin-cholesterol acyltransferase (LCAT) in human samples through applications such as western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), and enzyme-linked immunosorbent assay (ELISA). LCAT plays a vital role in lipid metabolism by catalyzing the esterification of cholesterol, which is essential for cholesterol transport in the bloodstream. This enzymatic activity maintains proper lipid levels and prevents free cholesterol accumulation, which can lead to atherosclerosis and other cardiovascular diseases. Additionally, LCAT is primarily located in plasma, where LCAT interacts with high-density lipoproteins (HDL) to facilitate free cholesterol conversion into cholesteryl esters, promoting reverse cholesterol transport. LCAT deficiencies can result in significant health issues, such as fish-eye disease, a rare genetic disorder characterized by abnormal HDL metabolism, underscoring LCAT′s importance in maintaining cardiovascular health. Anti-LCAT antibody (D-3) serves as an invaluable tool for researchers studying lipid metabolism and related disorders, providing reliable detection and analysis of this critical protein.
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
LCAT Antibody (D-3) | sc-377509 | 200 µg/ml | $322.00 | |||
LCAT Antibody (D-3): m-IgG Fc BP-HRP Bundle | sc-538048 | 200 µg Ab; 10 µg BP | $361.00 | |||
LCAT Antibody (D-3): m-IgGκ BP-HRP Bundle | sc-535574 | 200 µg Ab; 40 µg BP | $361.00 | |||
LCAT Antibody (D-3): m-IgG2a BP-HRP Bundle | sc-548187 | 200 µg Ab; 10 µg BP | $361.00 |